In applying for the Mentored Research Scientist Development Award, the principal investigator is requesting support for an intensive program of training under the supervision of Dr. Susan Lord, Professor of Pathology, and Dr. Robert Roubey, Associate Professor of Medicine, at the University of North Carolina at Chapel Hill. The objectives of this proposal are designed to strengthen the applicant's scientific background in the biochemical basis of coagulation and cell biology. The award, if funded, will facilitate the long-term goals of the applicant in developing an independent scientific research career in the field of hemostasis and thrombosis. The Candidate and her mentors have developed a career development plan which includes: a) assurance of protected research time of 100 %, b) a training program exposing the Candidate to new areas of scientific investigation in biochemistry, biology and medicine, and c) graduate level studies to reinforce the laboratory experience. The studies proposed in this application will extend the applicant's previous work in hemostasis and thrombosis research. The prevalence of venous thrombosis associated with the primary Antiphospholipid Syndrome (APS) may be as high as 0.3 to 1% of the general population, possibly making APS one of the most common autoimmune diseases. It is hypothesized that antibodies against the plasma protein B2GPI are involved in the pathogenesis of this disease. Annexin A2 has recently been identified as the cellular receptor for B2GPI. To study the biological and cellular interactions of anti-B2GPI antibodies, the following specific aims will be addressed: 1) Determining whether annexin A2 mediates anti-B2GPI antibody-regulated expression of TF activity, 2) Determining whether annexin A2-mediated fibrinolytic activity is regulated by B2GPI or B2GPI/anti-B2GPI, and 3) Determining whether APS autoantibodies alter the structure and fibrinolytic susceptibility of the fibrin clot. It is expected that these proposed studies will contribute to a fundamental understanding of pathogenic mechanisms for thrombosis in APS and lead to future investigations addressing therapeutic interventions in APS.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Scientist Development Award - Research & Training (K01)
Project #
Application #
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Gretz, Elizabeth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Schools of Medicine
Chapel Hill
United States
Zip Code
Ollivier, Veronique; Wang, Jianguo; Manly, David et al. (2010) Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thromb Res 125:90-6
Carter, J C; Campbell, R A; Gibbons, J A et al. (2010) Enhanced cell-associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells. J Thromb Haemost 8:1323-32
Machlus, Kellie R; Colby, Emily A; Wu, Jogin R et al. (2009) Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thromb Haemost 102:936-44
Campbell, Robert A; Overmyer, Katherine A; Selzman, Craig H et al. (2009) Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood 114:4886-96
Campbell, Robert A; Overmyer, Katherine A; Bagnell, C Robert et al. (2008) Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler Thromb Vasc Biol 28:2247-54
Wolberg, Alisa S; Campbell, Robert A (2008) Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci 38:15-23
Wolberg, Alisa S (2007) Thrombin generation assays: understanding how the method influences the results. Thromb Res 119:663-5
Allen, Geoffrey A; Persson, Egon; Campbell, Robert A et al. (2007) A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia. Arterioscler Thromb Vasc Biol 27:683-9
Wolberg, Alisa S (2007) Antiphospholipid antibody effects on monocytes. Curr Rheumatol Rep 9:198-204
Campbell, Robert A; Fischer, Thomas H; Wolberg, Alisa S (2007) A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation. Br J Haematol 138:82-93